DOWN, in all human PCa cell lines * a. Knockout mice of SLC30A7 accelerate prostate tumor formation in TRAMP mice (65% in 2 weeks), suggesting insufficient SLC30A7 activity may contribute to PCa progression. Here, SLC30A7 is linked to prostate neoplasm.